Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities

Inspire Veterinary Partners Inc

IVP:NAQ

Inspire Veterinary Partners Inc

Actions
Health CareHealth Care Providers
  • Price (USD)0.742
  • Today's Change-0.055 / -6.88%
  • Shares traded983.00
  • 1 Year change-99.59%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Inspire Veterinary Partners, Inc. owns and operates veterinary hospitals throughout the United States. It specializes in small animal general practice hospitals which serve all manner of companion pets, emphasizing canine and feline breeds and including equine care. Services provided at its hospitals include preventive care for companion animals consisting of annual health exams, including parasite control; dental health; nutrition and body condition counseling; neurological examinations; radiology; bloodwork; skin and coat health and many breed specific preventive care services. Surgical offerings include all soft tissue procedures, such as spays and neuters, mass removals, splenectomies and can also include gastropexies, orthopedic procedures and other types of surgical offerings based on a doctor’s training. In many locations, additional means of care and alternative procedures are also offered, such as acupuncture, chiropractic and various other health and wellness offerings.

  • Revenue in USD (TTM)17.13m
  • Net income in USD-19.33m
  • Incorporated2022
  • Employees156.00
  • Location
    Inspire Veterinary Partners Inc780 Lynnhaven Pkwy #400VIRGINIA BEACH 23452United StatesUSA
  • Phone+1 (757) 288-3088
  • Websitehttps://www.inspirevet.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Biocorrx Inc36.76k-4.29m3.51m5.00------95.48-0.4837-0.48370.0042-1.120.0595--0.3422---697.45-291.68----49.4067.13-11,718.77-3,208.40---2.96-----58.31-25.0413.79------
Medical Care Technologies Inc.0.00-1.07m3.97m0.00---------553,570.10-553,570.100.00-389.230.00-------154.94-----------------1.46---------40.06------
Syra Health Corp7.07m-4.19m4.58m78.00--1.47--0.6481-0.6709-0.67091.190.31692.81--11.2790,635.38-166.37---287.17--23.56---59.23-----177.320.0518---1.83---38.72------
CompuMed Inc1.78m-151.00k4.87m8.00--37.44--2.74-0.1337-0.13371.580.09972.3836.714.83---19.92-46.77-48.38-76.7850.4257.04-8.38-25.840.9493-2.930.7744---1.73-5.7164.41---18.75--
Selectis Health Inc37.33m-6.17m4.91m574.00------0.1315-2.02-2.0212.19-1.050.8922--15.6765,027.49-14.67-3.03-25.30-3.58-----16.44-4.84---2.981.11---9.4058.97-64.93---47.72--
Inspire Veterinary Partners Inc17.13m-19.33m5.55m156.00------0.3239-134.72-134.724.54-0.6310.816521.61246.52109,778.20-89.79---190.96--19.47---109.98--0.1311-2.741.20--69.56---206.68------
Novo Integrated Sciences Inc13.52m-24.33m5.89m127.00--0.5914--0.4356-1.38-1.380.79550.52250.38048.217.55106,432.80-68.51-29.43-113.88-35.6437.6839.59-180.11-110.250.2227-0.66790.2093--7.117.1759.77---22.73--
Ethema Health Corp5.27m943.69k6.18m65.003.64--6.071.170.00020.00020.0014-0.00220.6511--14.1781,064.167.10-37.68--------10.91-94.87---1.777.30--10.8765.34652.41--74.97--
NewGenIvf Group Ltd0.00-690.85k6.57m----0.1546-----0.1999-0.19990.004.190.00-------1.50---1.54--------------0.0944-------237.99------
Kindly MD Inc3.10m-2.44m7.14m23.00--1.63--2.30-0.4652-0.46520.57430.73760.98675.94471.36134,643.90-77.81---99.26--93.94---78.86--5.36-5.610.0517---0.488--36.34------
Interpace Biosciences Inc41.68m3.00m7.37m108.002.49--2.150.17680.6740.63029.46-2.852.8814.197.10385,888.9020.72-38.19---69.7359.0149.447.19-41.010.46954.95----26.3112.93118.96--0.9184--
Mangoceuticals Inc866.79k-9.13m7.48m----0.5267--8.63-0.4388-0.43880.0410.47470.093519.32-----98.48---107.62--58.19---1,052.90--0.3653-38.860.0134--8,082.22---361.07------
Caremax Inc784.55m-782.86m7.74m1.45k------0.0099-208.41-208.41208.34-38.730.9776--6.10541,069.60-97.55---160.21---3.31---99.78-----1.951.57--19.01---1,707.99------
Data as of Sep 20 2024. Currency figures normalised to Inspire Veterinary Partners Inc's reporting currency: US Dollar USD

Institutional shareholders

0.83%Per cent of shares held by top holders
HolderShares% Held
Citadel Securities LLCas of 31 Mar 20242.98k0.31%
MAI Capital Management LLCas of 31 Mar 20241.35k0.14%
Bartlett & Co. Wealth Management LLCas of 30 Jun 20241.31k0.14%
XTX Markets LLCas of 31 Mar 2024801.000.08%
HRT Financial LLCas of 31 Mar 2024543.000.06%
Kestra Advisory Services LLCas of 31 Mar 2024383.000.04%
Arbor Point Advisors LLCas of 31 Mar 2024218.000.02%
Osaic Wealth, Inc. (Investment Management)as of 31 Mar 2024200.000.02%
GTS Securities LLCas of 31 Mar 2024160.000.02%
Tower Research Capital LLCas of 31 Mar 202426.000.00%
More ▼
Data from 31 Mar 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.